Amy Parker Mph (Grekowicz)

Amy (Grekowicz) Parker, MPH has extensive experience in clinical operations and research. Amy is currently serving as the Vice President of Clinical Operations at Erasca, Inc. Prior to this, they held the same role at Oncternal Therapeutics from 2019 to 2022. At Oncternal Therapeutics, they also served as the Head of Clinical Operations from 2019 to 2020. Before that, Amy was the Executive Director of Clinical Operations at Oncolytics Biotech Inc. from 2017 to 2018. Amy has also held various roles at Pfizer, Medivation, FibroGen, Inc., Reputo Research, Pfizer/Kforce, CancerVax, and Stanford. Amy's responsibilities have included protocol development, study initiation, regulatory affairs, monitoring, safety reporting, closures, managing personnel, teaching seminars on Good Clinical Practice (GCP), developing standard operating procedures, and budgeting.

Amy (Grekowicz) Parker, MPH began their education at Rolling Hills High School, where they completed their secondary education from 1984 to 1988. Amy then attended UC San Diego from 1988 to 1992, where they obtained their Bachelor of Arts degree. In 1997, Amy enrolled at San Diego State University and earned their Master of Public Health (MPH) degree in Epidemiology.